Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-003132

Options or other derivatives

  • Chief Executive Officer acquired 3,988,560 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Rawcliffe Adrian Chief Executive Officer 2021-01-11 Grant or award · Option to purchase Ordinary Shares +3,260,400 3,260,400 D
Rawcliffe Adrian Chief Executive Officer 2021-01-11 Grant or award · Option to purchase Ordinary Shares +728,160 728,160 D
Loading xslF345X03/tm212800-4_4seq1.xml…